Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes
Phase 4
Recruiting
- Conditions
- Infertility UnexplainedInfertilityInfertility of Uterine OriginInfertility; Female, NonimplantationInfertility,Female
- Interventions
- Drug: Granulocyte Colony-Stimulating Factor (Filgrastim)Other: Standard Embryo Transfer Media
- First Posted Date
- 2023-12-18
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Newlife Fertility Centre
- Target Recruit Count
- 300
- Registration Number
- NCT06174298
- Locations
- 🇨🇦
Newlife Fertility Centre, Mississauga, Ontario, Canada
News
No news found